CL2013003445A1 - Método de detección de la lisil oxidasa tipo 2 (loxl2); dispositivo de ensayo para ser usado en la determinación del nivel de loxl2. - Google Patents

Método de detección de la lisil oxidasa tipo 2 (loxl2); dispositivo de ensayo para ser usado en la determinación del nivel de loxl2.

Info

Publication number
CL2013003445A1
CL2013003445A1 CL2013003445A CL2013003445A CL2013003445A1 CL 2013003445 A1 CL2013003445 A1 CL 2013003445A1 CL 2013003445 A CL2013003445 A CL 2013003445A CL 2013003445 A CL2013003445 A CL 2013003445A CL 2013003445 A1 CL2013003445 A1 CL 2013003445A1
Authority
CL
Chile
Prior art keywords
loxl2
detecting
determining
level
test device
Prior art date
Application number
CL2013003445A
Other languages
English (en)
Inventor
Lixin Shao
Victoria Smith
Joanne I Adamkewicz
Susan K Lyman
Jason Chien
Xiaoming Li
Jeffrey D Bornstein
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013003445(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of CL2013003445A1 publication Critical patent/CL2013003445A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
CL2013003445A 2011-06-01 2013-11-29 Método de detección de la lisil oxidasa tipo 2 (loxl2); dispositivo de ensayo para ser usado en la determinación del nivel de loxl2. CL2013003445A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21

Publications (1)

Publication Number Publication Date
CL2013003445A1 true CL2013003445A1 (es) 2014-07-25

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003445A CL2013003445A1 (es) 2011-06-01 2013-11-29 Método de detección de la lisil oxidasa tipo 2 (loxl2); dispositivo de ensayo para ser usado en la determinación del nivel de loxl2.

Country Status (24)

Country Link
US (3) US20120309020A1 (es)
EP (1) EP2714744A1 (es)
JP (3) JP2014523521A (es)
KR (1) KR20140048156A (es)
CN (1) CN103946241A (es)
AP (1) AP2013007285A0 (es)
AR (1) AR086657A1 (es)
AU (2) AU2012261883A1 (es)
BR (1) BR112013030682A2 (es)
CA (1) CA2837534A1 (es)
CL (1) CL2013003445A1 (es)
CO (1) CO6940375A2 (es)
CR (1) CR20130657A (es)
EA (1) EA201391627A1 (es)
EC (1) ECSP13013092A (es)
IL (1) IL229631A0 (es)
MA (1) MA35212B1 (es)
MD (1) MD20130098A2 (es)
MX (1) MX2013013905A (es)
PE (1) PE20141450A1 (es)
TW (1) TW201319572A (es)
UY (1) UY34115A (es)
WO (1) WO2012167181A1 (es)
ZA (1) ZA201308812B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
SI2185198T1 (sl) 2007-08-02 2015-04-30 Gilead Biologics, Inc. Inhibitorji LOX in LOXL2 ter njihova uporaba
WO2010080769A2 (en) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
SG2014004816A (en) 2009-08-21 2014-03-28 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
CA2789022A1 (en) 2010-02-04 2011-08-11 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
EP3348576A1 (en) * 2012-10-30 2018-07-18 Gilead Sciences, Inc. Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
BR112016028750A2 (pt) * 2014-06-11 2017-11-14 Gilead Sciences Inc ?métodos para tratar, prevenir, ou melhorar pelo menos um sintoma associado e para diagnosticar e monitorar insuficiência cardíaca ou fibrilação atrial, inibidor da lisil oxidase ativa ou proteína lisil tipo oxidase, e, composição?
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
EP3423057A1 (en) 2016-03-04 2019-01-09 Gilead Sciences, Inc. Compositions and combinations of autotaxin inhibitors
WO2017177179A1 (en) 2016-04-08 2017-10-12 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
SI2185198T1 (sl) * 2007-08-02 2015-04-30 Gilead Biologics, Inc. Inhibitorji LOX in LOXL2 ter njihova uporaba
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
BR112012008080A2 (pt) * 2009-08-21 2017-07-04 Gilead Biologics Inc ensaios de rastreamento in vivo.
CA2789022A1 (en) * 2010-02-04 2011-08-11 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
DE112012001731T5 (de) * 2011-05-10 2014-01-23 Borgwarner Inc. Turbolader mit variabler Turbinengeometrie

Also Published As

Publication number Publication date
MD20130098A2 (ro) 2014-06-30
EP2714744A1 (en) 2014-04-09
CA2837534A1 (en) 2012-12-06
EA201391627A1 (ru) 2014-08-29
JP2018049033A (ja) 2018-03-29
AU2016244254A1 (en) 2016-11-03
NZ618682A (en) 2016-04-29
MA35212B1 (fr) 2014-06-02
US20140206017A1 (en) 2014-07-24
ECSP13013092A (es) 2014-08-29
US20120309020A1 (en) 2012-12-06
WO2012167181A1 (en) 2012-12-06
ZA201308812B (en) 2014-08-27
IL229631A0 (en) 2014-01-30
AP2013007285A0 (en) 2013-11-30
JP2014523521A (ja) 2014-09-11
KR20140048156A (ko) 2014-04-23
CO6940375A2 (es) 2014-05-09
JP2016164578A (ja) 2016-09-08
CN103946241A (zh) 2014-07-23
UY34115A (es) 2013-01-03
CR20130657A (es) 2014-05-16
AU2016244254B2 (en) 2018-10-18
US20170269085A1 (en) 2017-09-21
AU2012261883A1 (en) 2013-05-02
PE20141450A1 (es) 2014-11-06
TW201319572A (zh) 2013-05-16
BR112013030682A2 (pt) 2016-12-06
MX2013013905A (es) 2014-05-14
AR086657A1 (es) 2014-01-15

Similar Documents

Publication Publication Date Title
CL2013003445A1 (es) Método de detección de la lisil oxidasa tipo 2 (loxl2); dispositivo de ensayo para ser usado en la determinación del nivel de loxl2.
BRPI1015026A2 (pt) método e aparelho para facilitar os procedimentos de medição em operação de multiportadora.
DK2567223T3 (da) Indretning til måling af den elektriske ledningsevne i et flydende, fortrinsvis vandigt, medium
DK2599877T3 (da) Hidtil ukendt pcr sekvenseringsfremgangsmåde og anvendelse deraf i hla-genotypebestemmelse
WO2013039477A8 (en) Non-invasive methods of detecting target molecules
BRPI1011886A2 (pt) solução contendo ácido hiplocloroso e métodos do uso do mesmo.
AT506816B1 (de) Vlf-prüfgenerator
CL2013003802A1 (es) Un dispositivo y metodo de medicion de gas para medir un gas en el estomago de un mamifero.
NO20085322L (no) Fremgangsmate for raskere ansiktsdeteksjon
SMT201600231B (it) Metodo per misurare la concentrazione di alcool nel respiro e relativo apparecchio
BR112015008621A2 (pt) Métodos e kit de diagnóstico e/ou prognóstico in vitro microconjunto de ácidos nucleicos.
PL2673345T3 (pl) Zastosowanie ciekłych kompozycji do znakowania ciekłych paliw silnikowych i paliw na bazie węglowodorów oraz sposób wykrywania znaczników
DK2349829T3 (da) Flydende tørdok
FI20125852L (fi) Nestetason mittausjärjestelmä
CL2014000315A1 (es) Proceso que sirve para medir cantidad de enzima digestiva liberada por composición en un medio que comprende usar espectroscopia de fluorescencia.
WO2012061068A3 (en) Method of using a tracer for monitoring water treatment agents in a wet air scrubber
DK2821338T3 (da) Livredningsindretning til anvendelse i vand
IT1401531B1 (it) Sistema utilizzabile in due modalita'
DK2335033T3 (da) In-line-måleapparat
BR112013013288A2 (pt) método, reagente e kit para medir um componente a ser medido em uma amostra, e, método para suprimir a influência de um peróxido sobre o dito método
EA201690434A1 (ru) Маркирующие соединения и их применение в анализах
FR2931651B1 (fr) Dispositif de mesure des proprietes mecaniques de la peau sans contact avec la zone de mesure.
DK2914286T3 (da) Hidtil ukendte immunterapeutiske molekyler og anvendelser deraf
EP3036528A4 (en) GENETICALLY USED CODED PROBE FOR QUANTIFYING PYRUVATE CONCENTRATION AND METHODS OF USING SAME
GB201202694D0 (en) Improvements in micro-sensor based test apparatus